Literature DB >> 1729686

Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products.

C Boitard1, M C Villa, C Becourt, H P Gia, C Huc, P Sempe, M M Portier, J F Bach.   

Abstract

The nonobese diabetic (NOD) mouse, in which major histocompatibility complex genes may be involved in the susceptibility to diabetes, has been developed as a model of autoimmune diabetes. The NOD mouse expresses I-A-encoded class II major histocompatibility complex antigens, which differ from those of other mouse haplotypes by the presence of a serine at position 57 of the A beta chain. Identifying islet autoantigens may help elucidate the role of class II antigens in the activation of autoreactive T cells and, thus, in the development of diabetes. We have detected autoantibodies directed against a 58-kDa islet cell antigen in NOD mice but not in other strains, including lupus-prone mice. Apart from insulin-secreting cells, the 58-kDa antigen was only found to be expressed by neuroblastoma cells and was identified as peripherin, an intermediate filament protein previously characterized in well-defined neuronal populations. This autoantigen cross-reacted with I-Anod class II antigens, suggesting that it may contribute to defective self-tolerance of islet beta cells in the NOD mouse.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729686      PMCID: PMC48198          DOI: 10.1073/pnas.89.1.172

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  Network antibodies identify nuclear lamin B as a physiological attachment site for peripherin intermediate filaments.

Authors:  K Djabali; M M Portier; F Gros; G Blobel; S D Georgatos
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

4.  "Cytoplasmic" islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate.

Authors:  R C Nayak; M A Omar; A Rabizadeh; S Srikanta; G S Eisenbarth
Journal:  Diabetes       Date:  1985-06       Impact factor: 9.461

5.  Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes.

Authors:  J A Shizuru; C Taylor-Edwards; B A Banks; A K Gregory; C G Fathman
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

8.  The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.

Authors:  H Acha-Orbea; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

9.  Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.

Authors:  A Miyazaki; T Hanafusa; K Yamada; J Miyagawa; H Fujino-Kurihara; H Nakajima; K Nonaka; S Tarui
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

10.  Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse.

Authors:  S Reddy; N J Bibby; R B Elliott
Journal:  Diabetologia       Date:  1988-05       Impact factor: 10.122

View more
  17 in total

Review 1.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

Review 2.  Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.

Authors:  Massimo Pietropaolo; Roberto Towns; George S Eisenbarth
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

3.  In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesis.

Authors:  Nahir Garabatos; Raimon Alvarez; Jorge Carrillo; Jorge Carrascal; Cristina Izquierdo; Harold D Chapman; Maximiliano Presa; Conchi Mora; David V Serreze; Joan Verdaguer; Thomas Stratmann
Journal:  J Immunol       Date:  2014-03-07       Impact factor: 5.422

Review 4.  IDDM: an islet or an immune disease?

Authors:  C Boitard; E Larger; J Timsit; P Sempe; J F Bach
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

5.  Peripherin-reactive antibodies in mouse, rabbit, and human blood.

Authors:  Alexander Strom; Brigitte Sonier; Harold D Chapman; Majid Mojibian; Gen-Sheng Wang; Cristina R Slatculescu; David V Serreze; Fraser W Scott
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

Review 6.  Islet autoantigens: structure, function, localization, and regulation.

Authors:  Peter Arvan; Massimo Pietropaolo; David Ostrov; Christopher J Rhodes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

7.  Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes Mellitus.

Authors:  Todd M Doran; Jumpei Morimoto; Scott Simanski; Eric J Koesema; Lorraine F Clark; Kevin Pels; Sydney L Stoops; Alberto Pugliese; Jay S Skyler; Thomas Kodadek
Journal:  Cell Chem Biol       Date:  2016-05-12       Impact factor: 8.116

8.  Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors.

Authors:  X D Yang; N Karin; R Tisch; L Steinman; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

9.  The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.

Authors:  Janet M Wenzlau; Kirstine Juhl; Liping Yu; Ong Moua; Suparna A Sarkar; Peter Gottlieb; Marian Rewers; George S Eisenbarth; Jan Jensen; Howard W Davidson; John C Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

10.  An Abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells.

Authors:  S M Singer; R Tisch; X D Yang; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.